Xaira Therapeutics is developing biological foundation models (not LLMs) to hit undruggable targets and cure disease. Not a SaaS company; the goal is to deliver medicines to patients. The team combines pharma veterans, AI scientists from Nobel laureate David Baker's lab, and engineers from tech to reimagine how drugs are made.